https://www.onhealthcare.tech/p/gpt-rosalind-lands-what-openais-firstThoughts on Healthcare Markets and Technologyen2026-04-18T11:59:15+00:00GPT-Rosalind Lands: What OpenAI’s First Domain-Specific Life Sciences Model, the Codex Life Sciences Plugin & the Trusted Access Program Actually Meanhttps://www.onhealthcare.tech/p/goodfire-ai-and-the-billion-dollarThoughts on Healthcare Markets and Technologyen2026-04-17T10:19:29+00:00Goodfire AI and the Billion Dollar Bet on Neural Network Interpretability: Why Reverse Engineering Foundation Models Matters for Health Tech Investors Watching the Life Sciences AI Stack Take Shapehttps://www.onhealthcare.tech/p/amazon-bio-discovery-what-aws-justThoughts on Healthcare Markets and Technologyen2026-04-17T10:06:34+00:00Amazon Bio Discovery: What AWS Just Launched, Why It Actually Matters for Drug Development, and What Health Tech Investors Need to Understand About the Platform War Now Playing Out in Life Scienceshttps://www.onhealthcare.tech/p/the-category-2-peptide-unwind-howThoughts on Healthcare Markets and Technologyen2026-04-16T19:47:21+00:00The Category 2 Peptide Unwind: How a Rogan Appearance, 14 Withdrawn Nominations & a July PCAC Docket Will Reprice the Compounding Pharmacy Stack, GLP-1 Gray Market, and Longevity Clinic Supply Chain